Please describe two of your most substantial, recent wins in practice.
During the COVID-19 pandemic, Latham advised DXC Technology (NYSE: DXC) on the $5 billion sale of its U.S. State and Local Health and Human Services business to Veritas Capital, and the $525 million sale of its healthcare software provider business to the Dedalus Group. Both deals were complex cross-border asset carve-out transactions that required significant effort to separate the businesses being sold. I am proud of the skill and adaptability demonstrated by Latham’s global, multidisciplinary deal team as we partnered with DXC to advise, negotiate and execute on these ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.